Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Voyager therapeutics, inc. symbols : PFE save search
Voyager Therapeutics Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
Published: 2023-03-07 (Crawled : 12:00) - ir.voyagertherapeutics.com
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: -0.12%
H: 0.17%
C: -1.75%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 0.63%
H: 0.12%
C: -8.36%
NBIX | News M | $133.66 1.26% 1.12% 460K
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: -2.54%
year therapeutics financial results
Voyager Therapeutics Reports Third Quarter 2022 Financial and Operating Results
Published: 2022-11-08 (Crawled : 12:20) - ir.voyagertherapeutics.com
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: -0.11%
H: 1.51%
C: 0.66%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 11.69%
H: 2.44%
C: -1.87%
therapeutics financial results
Voyager Therapeutics Announces Pfizer License of Next-Generation AAV Capsid for Rare Neurologic Disease Target
Published: 2022-10-04 (Crawled : 11:00) - ir.voyagertherapeutics.com
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: 0.25%
H: 1.33%
C: 0.47%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 6.57%
H: 13.17%
C: 10.17%
rare disease license therapeutics
Voyager Therapeutics Reports Third Quarter 2021 Financial and Operating Results
Published: 2021-11-02 (Crawled : 12:00) - globenewswire.com
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: 2.06%
H: 0.0%
C: 0.0%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: -0.95%
H: 7.4%
C: 6.58%
results therapeutics
Voyager Therapeutics Announces License Option Agreement with Pfizer for Next-Generation TRACERᵀᴹ AAV Capsids to Enable Neurologic and Cardiovascular Gene Therapy Programs
Published: 2021-10-06 (Crawled : 12:00) - biospace.com/
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: -0.61%
H: 0.33%
C: -0.1%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: 61.54%
H: 3.26%
C: -3.01%
cardiovascular gene therapy therapy license cardio aav9 gene therapies aav capsids
Aerovate Therapeutics Announces Second Quarter 2021 Financial Results
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
AVTE M | $22.17 0.54% 0.18% 110K
|
Professional, Scientific, and T...
|
| O: -8.86%
H: 4.83%
C: 3.51%
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: 1.54%
H: 1.53%
C: 1.41%
VYGR | News | $7.57 0.93% 0.92% 320K
|
Health Technology
|
| O: -3.31%
H: 2.05%
C: -1.37%
GILD | $66.95 0.29% 0.28% 3.8M
|
Health Technology
|
| O: 0.56%
H: 0.81%
C: 0.62%
financial results results therapeutics
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.